|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-19
|
|
pubmed:abstractText |
A multicenter randomized open-label crossover prospective trial was designed to compare the efficacy, safety, and cost of standard and high dosages of recombinant factor VIIa (rFVIIa) for home treatment of hemarthroses in hemophiliacs with inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
367-71
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16420567-Adolescent,
pubmed-meshheading:16420567-Adult,
pubmed-meshheading:16420567-Child,
pubmed-meshheading:16420567-Child, Preschool,
pubmed-meshheading:16420567-Cross-Over Studies,
pubmed-meshheading:16420567-Factor VIIa,
pubmed-meshheading:16420567-Hemarthrosis,
pubmed-meshheading:16420567-Hemophilia A,
pubmed-meshheading:16420567-Humans,
pubmed-meshheading:16420567-Infant,
pubmed-meshheading:16420567-Male,
pubmed-meshheading:16420567-Middle Aged,
pubmed-meshheading:16420567-Prospective Studies,
pubmed-meshheading:16420567-Recombinant Proteins,
pubmed-meshheading:16420567-Safety
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.
|
|
pubmed:affiliation |
Department of Internal Medicine and Dermatology, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation and University of Milan, Milan, Italy. hemophilia_ctr@policlinico.mi.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
